Brain Hemorrhage – Pipeline Review, H1 2013

Global Markets Direct
March 28, 2013
32 Pages - SKU: GMD5010940
Hematological Malignancies: Multiple Myeloma (MM) – Early and Robust Diagnosis along with New Treatment Options can have Considerable Impact on Management of the Disease
2/24/2015 | published by: MP Advisors
Hematological Malignancies: Multiple Myeloma (MM) – Early and Robust Diagnosis along with New Treatment Options can have Considerable Impact on Management of the Disease While targeting unmet needs in the treatment of hematological malignancies/ cancer through  |  read more...
USD 3,000
Pyrogen Testing Market by Product (Instruments, Services, Kits & Reagents), by Test (In Vitro, LAL, Rabbit Test), by Application (Pharmaceutical & Biotechnology Companies, Medical Devices, Other Applications) - Global Forecast to 2019
2/18/2015 | published by: MarketsandMarkets
Pyrogen Testing Market by Product (Instruments, Services, Kits & Reagents), by Test (In Vitro, LAL, Rabbit Test), by Application (Pharmaceutical & Biotechnology Companies, Medical Devices, Other Applications) - Global Forecast to 2019 Pyrogen testing  |  read more...
USD 4,650
A Product and Pipeline Analysis of the Lung Cancer Therapeutics Market
1/28/2015 | published by: Frost & Sullivan
A Product and Pipeline Analysis of the Lung Cancer Therapeutics Market The estimated market size for lung cancer therapeutics in 2014 was $?? billion. There is increasing competition in this market, especially amongst  |  read more...
USD 5,000
Anxiety Disorders-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Anxiety Disorders-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Anxiety Disorders-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Tension -Type Headache-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Tension -Type Headache-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Tension -Type Headache-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed  |  read more...
USD 2,000
Autism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Autism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Autism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Autism.  |  read more...
USD 2,000
Brain Hemorrhage-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Brain Hemorrhage-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Brain Hemorrhage-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Depression-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Depression-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Depression-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Depression.  |  read more...
USD 2,000
Global Migraine Drugs Market 2015-2019
2/4/2015 | published by: TechNavio - Infiniti Research Ltd.
Global Migraine Drugs Market 2015-2019 About Migraine Migraine is a complex neurological medicial condition characterized by a severe headache. The headache is often accompanied by nausea, vomiting, and extreme sensitivity to light and sound. Given their hormonal  |  read more...
USD 3,000
 

SELECT A LICENSE

    Online Download  USD 2,000  
    Site License  USD 4,000  
    Global Site License  USD 6,000  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!